Literature DB >> 25712477

Autophagy in malignant transformation and cancer progression.

Lorenzo Galluzzi1, Federico Pietrocola2, José Manuel Bravo-San Pedro2, Ravi K Amaravadi3, Eric H Baehrecke4, Francesco Cecconi5, Patrice Codogno6, Jayanta Debnath7, David A Gewirtz8, Vassiliki Karantza9, Alec Kimmelman10, Sharad Kumar11, Beth Levine12, Maria Chiara Maiuri2, Seamus J Martin13, Josef Penninger14, Mauro Piacentini15, David C Rubinsztein16, Hans-Uwe Simon17, Anne Simonsen18, Andrew M Thorburn19, Guillermo Velasco20, Kevin M Ryan21, Guido Kroemer22.   

Abstract

Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy.
© 2015 The Authors.

Entities:  

Keywords:  Beclin 1; KRAS; adaptive stress responses; inflammation; mitophagy

Mesh:

Substances:

Year:  2015        PMID: 25712477      PMCID: PMC4388596          DOI: 10.15252/embj.201490784

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  280 in total

1.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

Authors:  Baptiste Ronan; Odile Flamand; Lionel Vescovi; Christine Dureuil; Laurence Durand; Florence Fassy; Marie-France Bachelot; Annabelle Lamberton; Magali Mathieu; Thomas Bertrand; Jean-Pierre Marquette; Youssef El-Ahmad; Bruno Filoche-Romme; Laurent Schio; Carlos Garcia-Echeverria; Hélène Goulaouic; Benoit Pasquier
Journal:  Nat Chem Biol       Date:  2014-10-19       Impact factor: 15.040

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

Review 4.  Cell biology. Metabolic control of cell death.

Authors:  Douglas R Green; Lorenzo Galluzzi; Guido Kroemer
Journal:  Science       Date:  2014-09-19       Impact factor: 47.728

5.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

Review 6.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

7.  Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

Authors:  Amine Belaid; Michaël Cerezo; Abderrahman Chargui; Elisabeth Corcelle-Termeau; Florence Pedeutour; Sandy Giuliano; Marius Ilie; Isabelle Rubera; Michel Tauc; Sophie Barale; Corinne Bertolotto; Patrick Brest; Valérie Vouret-Craviari; Daniel J Klionsky; Georges F Carle; Paul Hofman; Baharia Mograbi
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

Review 8.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 9.  Caloric restriction mimetics: towards a molecular definition.

Authors:  Frank Madeo; Federico Pietrocola; Tobias Eisenberg; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2014-09-12       Impact factor: 84.694

10.  A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.

Authors:  Jonas Wolf; Dyah Laksmi Dewi; Johannes Fredebohm; Karin Müller-Decker; Christa Flechtenmacher; Jörg D Hoheisel; Michael Boettcher
Journal:  Breast Cancer Res       Date:  2013-11-14       Impact factor: 6.466

View more
  489 in total

1.  Small-molecule inhibitors: bULKing up mTOR inhibition.

Authors:  Jonathan M Goodwin; Leon O Murphy
Journal:  Nat Chem Biol       Date:  2015-10       Impact factor: 15.040

2.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

Review 3.  Programmed cell death 50 (and beyond).

Authors:  R A Lockshin
Journal:  Cell Death Differ       Date:  2015-11-13       Impact factor: 15.828

4.  Structure of the Human Atg13-Atg101 HORMA Heterodimer: an Interaction Hub within the ULK1 Complex.

Authors:  Shiqian Qi; Do Jin Kim; Goran Stjepanovic; James H Hurley
Journal:  Structure       Date:  2015-08-20       Impact factor: 5.006

Review 5.  Autophagy inhibitors.

Authors:  Benoit Pasquier
Journal:  Cell Mol Life Sci       Date:  2015-12-11       Impact factor: 9.261

6.  Nutrient Starvation Decreases Cx43 Levels and Limits Intercellular Communication in Primary Bovine Corneal Endothelial Cells.

Authors:  Catheleyne D'hondt; Jegan Iyyathurai; Kirsten Welkenhuyzen; Bernard Himpens; Luc Leybaert; Geert Bultynck
Journal:  J Membr Biol       Date:  2016-02-12       Impact factor: 1.843

7.  Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers.

Authors:  Mireia Nàger; Marta C Sallán; Anna Visa; Charumathi Pushparaj; Maria Santacana; Anna Macià; Andrée Yeramian; Carles Cantí; Judit Herreros
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

8.  Rab5a suppresses autophagy to promote drug resistance in cancer cells.

Authors:  Wenxia Xu; Qiqi Shi; Xiaoling Qian; Bingluo Zhou; Jinye Xu; Liyuan Zhu; Lifeng Feng; Hongchuan Jin; Xian Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

9.  Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition.

Authors:  Raymond Wu; Ramachandran Murali; Yasuaki Kabe; Samuel W French; Yi-Ming Chiang; Siyu Liu; Linda Sher; Clay C Wang; Stan Louie; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2018-10-09       Impact factor: 17.425

Review 10.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.